Suturion

Suturion is innovating a new suturing choice for abdominal wall closure. Suturion AB was founded in 2018 by Gabriel Börner, medtech engineer Mats O. Christensson and LU Holding AB. Suturion have performed extensive pre-clinical research and filed for several patents. In 2023 Suturion started a clinical trial which is an important step towards the regulatory pathway for CE and FDA approval.

Founded 2018
Investment year 2021
Invested through AB Segulah
CEO Paan Hermansson
Chairperson Göran Brorsson
Head Office Lund, Sweden
Formal Representation Gabriel Urwitz